Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells

Z Li, L Jiang, J Ni, Y Xu, F Liu, W Liu, S Wang… - Acta Pharmacologica …, 2023 - nature.com
UDP-glucose ceramide glucosyltransferase (UGCG) is the first key enzyme in
glycosphingolipid (GSL) metabolism that produces glucosylceramide (GlcCer). Increased …
被引用次数：6 相关文章

Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells

ZB Li, L Jiang, JD Ni, YH Xu, F Liu… - Acta …, 2023 - pubmed.ncbi.nlm.nih.gov
UDP-glucose ceramide glucosyltransferase (UGCG) is the first key enzyme in
glycosphingolipid (GSL) metabolism that produces glucosylceramide (GlcCer). Increased …
[PDF] researchgate.net

[PDF][PDF] Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells

Z Li, L Jiang, J Ni, Y Xu, F Liu, W Liu, S Wang, Z Liu… - researchgate.net
UDP-glucose ceramide glucosyltransferase (UGCG) is the first key enzyme in
glycosphingolipid (GSL) metabolism that produces glucosylceramide (GlcCer). Increased …

Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells.

ZB Li, L Jiang, JD Ni, YH Xu, F Liu, WM Liu… - Acta Pharmacologica …, 2023 - europepmc.org
UDP-glucose ceramide glucosyltransferase (UGCG) is the first key enzyme in
glycosphingolipid (GSL) metabolism that produces glucosylceramide (GlcCer). Increased …